Navigation Links
USC researchers identify key mechanism that guides cells to form heart tissue
Date:3/17/2010

Los Angeles, Calif., March 16, 2010Researchers at the Keck School of Medicine of the University of Southern California (USC) have identified a key cellular mechanism that guides embryonic heart tissue formationa process which, if disrupted, can lead to a number of common congenital heart defects.

Heart tissue forms in two distinct phases known as the First Heart Field, which includes the left ventricle and portions of both atrial chambers, and the Second Heart Field (SHF), which consists of the right ventricle and outflow tract. In humans, the process occurs within the fourth week of development. Using animal models, Keck School of Medicine researchers found that retinoic acid (RA), a derivative of vitamin A, regulates the SHF tissue formation and the septation, or division, of the outflow tract into the ascending aorta and the pulmonary artery.

The study appears in the March 16 issue of the journal Developmental Cell.

"This study provides us with a much deeper understanding of the biology of second heart field development," said principal investigator Henry Sucov, Ph.D., associate professor of Cell and Neurobiology at the Keck School of Medicine and a researcher at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC. "We now know that vitamin A is a critical regulator of this process, and too much or too little RA can lead to common congenital defects."

RA is a signaling molecule that causes progenitor cells (cells that have the capacity to differentiate into many different kinds of cells) to take the first step towards differentiating into heart tissue. Using specific molecular markers, researchers were able to observe the process by which the cells moved to the outflow tract and began to form essential heart tissue.

The process of moving cells to form the outflow tract is similar to a conveyer belt, Sucov explained. However, in animal models that were mutated to have an RA receptor deficiency, the entire process was halted, resulting in an outflow tract that was shortened and misaligned.

When development of the SHF is compromised, alignment defects such as double outlet right ventricle (DORV; the aorta and pulmonary trunk both exit from the right ventricle) or overriding aorta (when the aorta straddles the interventricular septum) occur. Problems in SHF development can also compromise the septation process resulting in a single outflow vessela condition known as persistent truncus arteriosus. These malformations occur commonly in human infants.

"This exciting research shows how retinoic acid, a vitamin A derivative, acts to guide cells in the embryo to form parts of the heart and the major blood vessels that emerge from it," said Martin Pera, Ph.D., director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC. "Defects in this developmental pathway can result in serious congenital malformations of the heart in the fetus and newborns, that may be fatal if not corrected surgically."

Further research is needed to examine how the findings may be used to correct human heart defects, Sucov said, noting that specific treatments suggested by these results and testing in animal models will soon be underway.

"Through this research, preventative strategies that prevent the occurrence of these defects may be realized," he said.


'/>"/>

Contact: Meghan Lewit
lewit@usc.edu
323-442-3941
University of Southern California
Source:Eurekalert

Related biology news :

1. Frogs, foam and fuel: University of Cincinnati researchers convert solar energy to sugars
2. U-M researchers solve a molecular mystery in muscle
3. Researchers introducing sustainable agriculture practices to improve food security
4. Carnegie Mellon researchers seek to control blood loss
5. Researchers characterize stem cell function
6. Penn researchers identify immune cells that fight parasites may promote allergies and asthma
7. VAI researchers develop tool to help study prostate cancer
8. Researchers examine plants ability to identify, block invading bacteria
9. Community involvement important in fight against childhood obesity, according to UTHealth researchers
10. Exercise counters negative effects of weight regain, researchers find
11. Rice researchers make graphene hybrid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial ... ...
(Date:3/7/2017)... -- Brandwatch , the leading social intelligence company, today announces ... to uncover insights to support its reporting, help direct future campaigns, ... leading youth charity will be using Brandwatch Analytics social listening and ... understanding of the topics and issues that are a priority for ... "Until ...
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. ... Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate ... U.K. Biobank resource. The initiative will enable researchers to gain ... medicines for a wide range of serious and life threatening ... ...
(Date:3/22/2017)... JERUSALEM , March 22, 2017 ... ( www.oramed.com ), ... of oral drug delivery systems, announced today that ... Officer, will deliver a presentation titled, "Oral Insulin ... upcoming Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical ... cancer therapeutics designed to target cancer stemness pathways, today ... S. Andrews as Chief Executive Officer, effective April ... Chiang J. Li , M.D., FACP, who has ... years ago. Under his leadership, Boston Biomedical has grown ...
Breaking Biology Technology: